Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Hormonal Blockade and Chemotherapy in HR+, HER2- Breast Cancer
NCT00194792Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Aug 2005
- Primary completion
- Jul 2011
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of exemestane, triptorelin pamoate, capecitabine, methotrexate, vinorelbine in breast cancer, sponsored by University of Washington. Started Aug 2005; status: terminated.
02
Drugs
exemestanetriptorelin pamoatecapecitabinemethotrexatevinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00194792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194792.